Coming in 2022

Formulation Development Overview

Beginning in 2022 Salubrent’s pharmaceutical experts will be ready to take on the toughest formulation challenges. Here are some of the capabilities and services we’ll offer:

Formulation Development

  • Accelerated first-in-human clinical trial materials
  • API polymorph screening
  • API salt form selection
  • API structural chemistry
  • Bioavailabilty enhancement
  • Blinding and over-encapsulation
  • Clinical formulation development
  • Commercial dosage form design
  • Drug candidate selection
  • Drug excipient compatibility studies
  • Drug product lifecycle management
  • Drug substance preformulation studies
  • Injectable prototype development
  • Matching placebo development
  • Pediatric formulation development
  • Pharmaceutical process development
  • Powders for reconstitution
  • Preclinical formulation development
  • Quality-by-Design (QbD)
  • Solid oral dose prototype development
  • Technology transfer and process scale-up